Pentamidine Isethionate | CAS#140-64-7

Pentamidine Isethionate
featured

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 318465

CAS#: 140-64-7

Description: Pentamidine isethionate inhibits constitutive NOS1 in the brain and acts as a NMDA Glu antagonist. Pentamidine isethionate is an antimicrobial and neuroprotective agent.

Chemical Structure

Pentamidine Isethionate

CAS# 140-64-7

Instruction

Theoretical Analysis

MedKoo Cat#: 318465
Name: Pentamidine Isethionate
CAS#: 140-64-7
Chemical Formula: C23H36N4O10S2
Exact Mass: 0.00
Molecular Weight: 592.680
Elemental Analysis: C, 46.61; H, 6.12; N, 9.45; O, 26.99; S, 10.82

Price and Availability

Size	Price	Availability	Quantity
100mg	USD 150
200mg	USD 250
500mg	USD 450
1g	USD 650
Bulk inquiry Welcome, Customer: Please do not inquire quote if your intended use is for a patient since our products are for research use and for chemical synthesis use, not for human use . For in-stock products, we listed price in the web page. You may inquire prices for which sizes were not listed. If no price is listed, this means the product is not in stock at the moment, which may be available via custom synthesis. For cost-effective reason, minimum order of 1g is requested (typically very expensive). The lead time is usually 2-4 months. Quote of less than 1g will not be provided. MedKoo may not offer quote for below reasons: (1) current available synthetic method appears to be extremely expensive which is obviously not affordable to most customers; (2) Key raw material to make the product is temporally not available; (3) DEA controlled substances; (4) the product is under patent protection in customer’s country.

Synonym: Pentamidine Isethionate; Pentamidine isethionate salt; Pentamidine diisethionate; 4,4'-(Pentane-1,5-diylbis(oxy))dibenzimidamide bis(2-hydroxyethanesulfonate); Pentamidine (isethionate);Pentamidine Mesylate; Rhône-Poulenc Rorer Brand of Pentamidine Isethionate; Sicor Brand of Pentamidine Isethionate;

IUPAC/Chemical Name: 4,4'-(Pentamethylenedioxy)-dibenzamidine bis(2-hydroxyethanesulfonate)4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide;2-hydroxyethanesulfonic acid

InChi Key: YBVNFKZSMZGRAD-UHFFFAOYSA-N

InChi Code: InChI=1S/C19H24N4O2.2C2H6O4S/c20-18(21)14-4-8-16(9-5-14)24-12-2-1-3-13-25-17-10-6-15(7-11-17)19(22)23;2*3-1-2-7(4,5)6/h4-11H,1-3,12-13H2,(H3,20,21)(H3,22,23);2*3H,1-2H2,(H,4,5,6)

SMILES Code: C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N.C(CS(=O)(=O)O)O.C(CS(=O)(=O)O)O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Instruction:

View handling instruction

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 592.68 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt* g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1

Volume 1

Concentration 2

Volume 2

1: Mans DR, Kent AD, Hu RV, Lai A Fat EJ, Schoone GJ, Adams ER, Rood EJ, Alba S,
Sabajo LO, Lai A Fat RF, de Vries HJ, Schallig HD. Monitoring the response of
patients with cutaneous leishmaniasis to treatment with pentamidine isethionate
by quantitative real-time PCR, and identification of Leishmania parasites not
responding to therapy. Clin Exp Dermatol. 2015 Dec 9. doi: 10.1111/ced.12786.
[Epub ahead of print] PubMed PMID: 26648589.

2: Hu RV, Straetemans M, Kent AD, Sabajo LO, de Vries HJ, Fat RF. Randomized
single-blinded non-inferiority trial of 7 mg/kg pentamidine isethionate versus 4
mg/kg pentamidine isethionate for cutaneous leishmaniaisis in Suriname. PLoS Negl
Trop Dis. 2015 Mar 20;9(3):e0003592. doi: 10.1371/journal.pntd.0003592.
eCollection 2015 Mar. PubMed PMID: 25793773; PubMed Central PMCID: PMC4368628.

3: Orgel E, Rushing T. Efficacy and tolerability of intravenous pentamidine
isethionate for Pneumocystis jiroveci prophylaxis in a pediatric oncology
population. Pediatr Infect Dis J. 2014 Mar;33(3):319-21. doi:
10.1097/INF.0000000000000044. PubMed PMID: 24030353.

4: Sundaramurthi P, Burcusa MR, Suryanarayanan R. Physical characterization of
pentamidine isethionate during freeze-drying-relevance to development of stable
lyophilized product. J Pharm Sci. 2012 May;101(5):1732-43. doi:
10.1002/jps.23055. Epub 2012 Jan 23. PubMed PMID: 22271285.

5: Akpa PO, Ezeokonkwo RC, Eze CA, Anene BM. Comparative efficacy assessment of
pentamidine isethionate and diminazene aceturate in the chemotherapy of
Trypanosoma brucei brucei infection in dogs. Vet Parasitol. 2008 Feb
14;151(2-4):139-49. Epub 2007 Nov 19. PubMed PMID: 18155842.

6: Roussel M, Nacher M, Frémont G, Rotureau B, Clyti E, Sainte-Marie D, Carme B,
Pradinaud R, Couppié P. Comparison between one and two injections of pentamidine
isethionate, at 7 mg/kg in each injection, in the treatment of cutaneous
leishmaniasis in French Guiana. Ann Trop Med Parasitol. 2006 Jun;100(4):307-14.
PubMed PMID: 16762111.

7: Lightburn E, Morand JJ, Meynard JB, Kraemer P, Chaudier B, Pages F, Garnotel
E, Patte JH, Banzet S, Dampierre H, Lepage J, Morillon M, Boutin JP, Hovette P,
Chouc C. [Management of American cutaneous leishmaniasis. Outcome apropos of 326
cases treated with high-dose pentamidine isethionate]. Med Trop (Mars).
2003;63(1):35-44. French. PubMed PMID: 12891748.

8: Delobel P, Pradinaud R. Rhabdomyolysis associated with pentamidine isethionate
therapy for American cutaneous leishmaniasis. J Antimicrob Chemother. 2003
May;51(5):1319-20. Epub 2003 Mar 28. PubMed PMID: 12668576.

9: Hellier I, Dereure O, Tournillac I, Pratlong F, Guillot B, Dedet JP, Guilhou
JJ. Treatment of Old World cutaneous leishmaniasis by pentamidine isethionate. An
open study of 11 patients. Dermatology. 2000;200(2):120-3. PubMed PMID: 10773699.

10: Beach JR, Campbell M, Andrews DJ. Exposure of health care workers to
pentamidine isethionate. Occup Med (Lond). 1999 May;49(4):243-5. PubMed PMID:
10474916.

11: Chongprasert S, Griesser UJ, Bottorff AT, Williams NA, Byrn SR, Nail SL.
Effects of freeze-dry processing conditions on the crystallization of pentamidine
isethionate. J Pharm Sci. 1998 Sep;87(9):1155-60. PubMed PMID: 9724570.

12: Watts RG, Conte JE Jr, Zurlinden E, Waldo FB. Effect of charcoal
hemoperfusion on clearance of pentamidine isethionate after accidental overdose.
J Toxicol Clin Toxicol. 1997;35(1):89-92. PubMed PMID: 9022658.

13: Pérez-Molina JA, López-Vélez R, Montilla P, Guerrero A. Pentamidine
isethionate as secondary prophylaxis against visceral leishmaniasis in
HIV-positive patients. AIDS. 1996 Feb;10(2):237-8. PubMed PMID: 8838721.

14: Selkirk JK, He C, Merrick BA. Gel electrophoretic analysis of cellular and
secreted proteins from resting and activated rat alveolar macrophages treated
with pentamidine isethionate. J Chromatogr A. 1995 Sep 22;711(2):331-7. PubMed
PMID: 7581850.

15: Partisani M, Fraisse P, De Mautort E, Rey D, Lang JM. [High incidence of
bullous pulmonary lesions before pentamidine isethionate aerosols. 35 cases].
Presse Med. 1994 Dec 10;23(39):1831. French. PubMed PMID: 7899308.

16: Hiles RA, Mong S, Bekersky I, Banks C, Lulham G, Tellier P. Inhalation
toxicity of aerosolized pentamidine isethionate in rats and dogs. Fundam Appl
Toxicol. 1994 Oct;23(3):382-90. PubMed PMID: 7835539.

17: Williams NA, Schwinke DL. Low temperature properties of lyophilized solutions
and their influence on lyophilization cycle design: pentamidine isethionate. J
Pharm Sci Technol. 1994 May-Jun;48(3):135-9. PubMed PMID: 8069514.

18: Salah A, Lortholary O, Lhote F, Cohen P, Guillevin L. [Acute pancreatitis
induced by pentamidine isethionate in aerosols]. Presse Med. 1994 Jan
8-15;23(1):49. French. PubMed PMID: 8127816.

19: Anees M, Steven FS. Inhibition of a tumour protease with
3,4-dichloroisocoumarin, pentamidine-isethionate and guanidino derivatives. J
Enzyme Inhib. 1994;8(3):213-21. PubMed PMID: 7539490.

20: Belsito DV. Contact urticaria from pentamidine isethionate. Contact
Dermatitis. 1993 Sep;29(3):158-9. PubMed PMID: 8222633.

Your view history

Pentamidine Isethionate featured